Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB): Price and Financial Metrics
TRIB Price/Volume Stats
| Current price | $0.98 | 52-week high | $1.50 |
| Prev. close | $0.90 | 52-week low | $0.80 |
| Day low | $0.88 | Volume | 66,800 |
| Day high | $1.00 | Avg. volume | 29,971 |
| 50-day MA | $0.95 | Dividend yield | N/A |
| 200-day MA | $1.10 | Market Cap | 37.35M |
TRIB Stock Price Chart Interactive Chart >
TRIB Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for TRIB is -34.37 -- better than just 0.71% of US stocks.
- TRIB's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.28 -- higher than merely 3.98% of US-listed equities with positive expected earnings growth.
- TRIB's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 98.61% of US stocks.
- If you're looking for stocks that are quantitatively similar to TRINITY BIOTECH PLC, a group of peers worth examining would be KLDI, YAYO, VERO, LOV, and DTSS.
- Visit TRIB's SEC page to see the company's official filings. To visit the company's web site, go to www.trinitybiotech.com.
TRIB Valuation Summary
- TRIB's EV/EBIT ratio is -6.1; this is 150.83% lower than that of the median Healthcare stock.
- Over the past 224 months, TRIB's price/earnings ratio has gone down 8.1.
Below are key valuation metrics over time for TRIB.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TRIB | 2023-05-23 | 0.5 | -16.1 | -0.9 | -6.1 |
| TRIB | 2023-05-22 | 0.5 | -16.8 | -0.9 | -6.2 |
| TRIB | 2023-05-19 | 0.5 | -16.8 | -0.9 | -6.2 |
| TRIB | 2023-05-18 | 0.5 | -16.5 | -0.9 | -6.2 |
| TRIB | 2023-05-17 | 0.5 | -17.1 | -0.9 | -6.3 |
| TRIB | 2023-05-16 | 0.5 | -16.2 | -0.9 | -6.1 |
TRIB Growth Metrics
- The 3 year net income to common stockholders growth rate now stands at 71.27%.
- The 4 year price growth rate now stands at -37.23%.
- Its 2 year price growth rate is now at 48.28%.
The table below shows TRIB's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2020-12-31 | 101.98 | 24.671 | -6.388 |
| 2019-12-31 | 90.435 | 5.875 | -28.914 |
| 2018-12-31 | 97.035 | 5.978 | -22.09 |
| 2017-12-31 | 99.14 | 9.37 | -40.27 |
| 2016-12-31 | 99.611 | 10.556 | -100.625 |
Trinity Biotech plc each representing 4 A Ordinary Shares (TRIB) Company Bio
Trinity Biotech plc develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The company was founded in 1992 and is based in Bray, Ireland.
Latest TRIB News From Around the Web
Below are the latest news stories about TRINITY BIOTECH PLC that investors may wish to consider to help them evaluate TRIB as an investment opportunity.
Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleDUBLIN, Ireland, May 05, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today reported the receipt of a formal notification from The Nasdaq Stock Market LLC ("Nasdaq") that the Company has regained compliance with Listing Rule 5450(a)(1), which requires the Company's ordinary shares to maintain a minimum bid price of $1.00 per share. The Nasdaq staff m |
Trinity Biotech Announces the Successful Closing of the $30 Million Sale of its Life Sciences Supply Business to BiosynthDUBLIN, Ireland, April 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that it has closed the recently announced sale of its Fitzgerald Industries life sciences supply business, consisting of Benen Trading Ltd and Fitzgerald Industries International, Inc, to Biosynth for cash proceeds of approximately $30 million subject to customary |
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price RequirementDUBLIN, Ireland, April 24, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced that on April 19, 2023 the Company received notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 555(a)(2), as the minimum bid price of the Company’s American depositary shares (“ADSs”) ha |
This Trinity Biotech plc (NASDAQ:TRIB) Analyst Is Way More Bearish Than They Used To BeOne thing we could say about the covering analyst on Trinity Biotech plc ( NASDAQ:TRIB ) - they aren't optimistic... |
Trinity Biotech Announces the $30 Million Sale of its Life Sciences Supply Business to BiosynthDUBLIN, Ireland, April 20, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced it has entered into an agreement to sell its Fitzgerald Industries life sciences supply business, consisting of Benen Trading Ltd and Fitzgerald Industries International, Inc, to Biosynth for cash proceeds of approximately $30 million subject to customary adjustme |
TRIB Price Returns
| 1-mo | -4.39% |
| 3-mo | -5.77% |
| 6-mo | -22.22% |
| 1-year | -31.94% |
| 3-year | -26.32% |
| 5-year | -78.74% |
| YTD | -1.01% |
| 2022 | -30.77% |
| 2021 | -62.47% |
| 2020 | 268.69% |
| 2019 | -54.87% |
| 2018 | -55.10% |
Continue Researching TRIB
Want to do more research on Trinity Biotech Plc's stock and its price? Try the links below:Trinity Biotech Plc (TRIB) Stock Price | Nasdaq
Trinity Biotech Plc (TRIB) Stock Quote, History and News - Yahoo Finance
Trinity Biotech Plc (TRIB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...